News
September 20, 2007 - Medicure Inc. today announced the completion of enrollment of 3,000 patients in its MEND-CABG II trial, as the company plans to develop the first cardioprotective therapy approved to reduce mortality and morbidity in the CABG patient population.
September 19, 2007
News
September 19, 2007 - With better quality sound, reproducibility potential for computer analysis, file-sharing and ...
September 18, 2007News
September 19, 2007 - MedicalCV Inc. announced that the first closed-chest, beating heart cardiac ablation using the ...
September 18, 2007Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
September 18, 2007- With PET-guided lead placement, cardiac resynchronization therapy (CRT) can achieve significant clinical improvement in patients with severe ischemic heart failure, even in the presence of extensive scarring, reported investigators at the American Society of Nuclear Cardiology meeting, held in San Diego, CA, from September 6 – 9.
September 18, 2007News
September 19, 2007 - For patients with equivocal or discordant findings on myocardial perfusion imaging, CT angiography ...
September 18, 2007News
September 19, 2007 - Biotronik announced that it has been awarded a full-service cardiac rhythm management (CRM) ...
September 18, 2007Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
September 19, 2007 - Risk stratification using single-photon emission computed tomography (SPECT) led to shorter stays ...
September 18, 2007News
September 19, 2007 - Polymer Technology Systems Inc. (PTS) announced the availability of a new PTS Panels Test Strip to test important risk factors for cardiovascular disease and diabetes.
September 18, 2007News
September 18, 2007 - Angiotech Pharmaceuticals Inc. announced that it reached a favorable agreement with Johnson & ...
September 17, 2007Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
September 18, 2007 - Forty-one U.S. hospitals have been named 2007 Leapfrog Top Hospitals, based on results from the ...
September 17, 2007News
September 18, 2007 - The DuraHeart Left Ventricular Assist System (LVAS) reported a survival rate of 77 percent for all ...
September 17, 2007News
September 18, 2007 - Vasogen Inc. announced plans for a confirmatory study of its Celacade technology for the treatment ...
September 17, 2007Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
September 18, 2007 - Baseline data from the largest study of U.S.-based heart failure (HF) patients in the outpatient ...
September 17, 2007News
September 18, 2007 – CardioDynamics, an impedance cardiography (ICG) technology developer, announced plans to accelerate ...
September 17, 2007News
September 18, 2007 - St. Jude Medical Inc. announced FDA approval of its first radiofrequency (RF) wireless devices to treat patients with heart failure and with potentially lethal heart arrhythmias.
September 17, 2007© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now